Difference between revisions of "Part:BBa K2688000:Design"
m (→Source) |
|||
Line 17: | Line 17: | ||
===Source=== | ===Source=== | ||
− | Cpg2 is an enzyme originally isolated from | + | Cpg2 is an enzyme originally isolated from Pseudomonas strain RS-16. |
===References=== | ===References=== |
Latest revision as of 15:57, 1 August 2018
cpg2_cytosolic
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 57
Illegal NgoMIV site found at 745 - 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 844
Design Notes
This CDS was edited by removal of the signal peptide, allowing a cytosolic location instead of the uusual periplasmic location.
This CDS was codon optimized for E. Coli. (original sequence had higher GC and differing codon bias).
The sequence was designed so that the protein product is identical to the drug Voraxase(r) (INN: glucarpidase) used in methotrexate poisonning.
Source
Cpg2 is an enzyme originally isolated from Pseudomonas strain RS-16.